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Role of Adaptor TrfA and ClpPC in Controlling Levels of SsrA-Tagged
Proteins and Antitoxins in Staphylococcus aureus
Niles P. Donegan,a Jonathan S. Marvin,b Ambrose L. Cheunga
Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USAa; Janelia Farm Research Campus, Howard
Hughes Medical Institute, Ashburn, Virginia, USAb

Staphylococcus aureus responds to changing extracellular environments in part by adjusting its proteome through alterations of
transcriptional priorities and selective degradation of the preexisting pool of proteins. In Bacillus subtilis, the proteolytic adaptor protein MecA has been shown to play a role in assisting with the proteolytic degradation of proteins involved in competence
and the oxidative stress response. However, the targets of TrfA, the MecA homolog in S. aureus, have not been well characterized. In this work, we investigated how TrfA assists chaperones and proteases to regulate the proteolysis of several classes of proteins in S. aureus. By fusing the last 3 amino acids of the SsrA degradation tag to Venus, a rapidly folding yellow fluorescent protein, we obtained both fluorescence-based and Western blot assay-based evidence that TrfA and ClpCP are the adaptor and
protease, respectively, responsible for the degradation of the SsrA-tagged protein in S. aureus. Notably, the impact of TrfA on
degradation was most prominent during late log phase and early stationary phase, due in part to a combination of transcriptional regulation and proteolytic degradation of TrfA by ClpCP. We also characterized the temporal transcriptional regulation
governing TrfA activity, wherein Spx, a redox-sensitive transcriptional regulator degraded by ClpXP, activates trfA transcription
while repressing its own promoter. Finally, the scope of TrfA-mediated proteolysis was expanded by identifying TrfA as the
adaptor that works with ClpCP to degrade antitoxins in S. aureus. Together, these results indicate that the adaptor TrfA adds
temporal nuance to protein degradation by ClpCP in S. aureus.

T

he Gram-positive human pathogen Staphylococcus aureus
causes invasive infections of the skin and bloodstream that can
lead to life-threatening sepsis, endocarditis, and toxin-mediated
syndrome (1). Unfortunately, transmission and infection are
commonplace in hospitals and are increasing in frequency in
community settings (2). This scenario is in part due to the ability
of S. aureus to survive and spread from abiotic surfaces, such as
gloves (3) and clothing (4), as well as from biotic niches, like the
anterior nares of healthy adults (5).
The transcriptional regulation of numerous stress response
mechanisms that facilitate its survival is well described (6, 7).
However, posttranslational modifications of the proteome in S.
aureus are poorly characterized in comparison, even though they
play a significant role in the stress response and general housekeeping in many prokaryotes (8). These adjustments include recovery of denatured or aggregated proteins via GroEL- and ClpBmediated refolding (9), tuning of the temporal and spatial
activities of downstream regulatory networks (10), offsetting of
starvation by increasing the available pools of amino acids (11),
and hedging against unregulated cell death via toxin-antitoxin
system activation (12, 13).
In S. aureus, proteolytic degradation is carried out by the intracellular proteases ClpP, FtsH, and ClpQ (also known as HslV).
Of the three, ClpP appears to have the greatest impact in shaping
the S. aureus proteome (14), and when disrupted, it causes significant defects in growth, survival, virulence gene expression, and
cell wall maintenance (15, 16). FtsH has a modest role in regulating growth, stress resistance, starvation survival, and pathogenicity (17), but with a putative localization to the inner membrane, it
is thought to mainly degrade membrane-bound targets. Very little
is known about ClpQ, in part because a ⌬clpQ mutant of S. aureus
exhibits few phenotypes (18) and shows few alterations to stress
responses.
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The manner in which a protein is specifically degraded by one
of these proteases is initiated by the identification of a degradation
motif during partial ATP-dependent unwinding of the target (19).
FtsH contains its own intrinsic unwinding domain to facilitate this
process, but ClpP and ClpQ must associate with a member of the
AAA⫹ ATPase family of chaperones (19) to accomplish this. This
association with ClpP or ClpQ allows chaperones to unwind and
deliver identified targets into the cognate protease’s catalytic
chamber.
S. aureus has three known chaperones that aid in ClpP- and
ClpQ-mediated proteolysis, while a related fourth chaperone,
ClpL, lacks the structures necessary to interact with ClpP or ClpQ
(20). The chaperone ClpY (also known as HslU) assists ClpQ in
recognition of target motifs, and strains lacking clpY have phenotypes similar to those of strains lacking clpQ (18), suggesting that
few other partners exist for this chaperone/protease pair. The
ClpC and ClpX chaperones associate with ClpP, with each selecting different groups of proteins for ClpP-mediated proteolysis.
ClpX is primarily involved in virulence regulation (16), while
ClpC tunes how the cell regulates its oxidative stress response (21),
tricarboxylic acid cycle (21), toxin-antitoxin system activity (22),
and survival in resource-limited medium (23).
Members of a second class of proteins called adaptors assist
chaperones in controlling the proteolytic degradation of target
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substrates (8). These proteins lack the AAA⫹ ATPase activity
found in chaperones and instead facilitate motif identification either through direct interactions with a target (24), through selective motif occlusion (25), or by modification of a protein to alter
its degradation rate (26). On the basis of homology to adaptors
identified in Bacillus subtilis, there are at least three adaptors in S.
aureus, namely, McsB (SA0482), YjbH (SA0860), and TrfA
(SA0857). Studies have indicated the involvement of each in various stress responses (27–29), but many gaps remain in our understanding of the various roles played by these adaptors in S.
aureus. Details of the protein targets of these S. aureus adaptors are
limited, and to date, only two target proteins have been described
to be regulated by S. aureus adaptors. McsB targets CtsR for ClpCP
degradation (30), and the levels of the redox-sensing transcriptional regulator Spx have been shown to be controlled by the
adaptor YjbH (31).
In this work, we investigated how the chaperones and adaptors
of S. aureus assist in the proteolysis of several classes of proteins.
More specifically, we found that the ClpCP proteolytic system
and not the ClpXP system described in Escherichia coli (32) and
B. subtilis (33) is essential for SsrA-tagged protein destruction in
S. aureus. The adaptor TrfA was discovered to mediate this
breakdown, primarily during late-logarithmic- and early-stationary-phase growth. This regulation is likely a result of the
transcriptional regulation as well as the growth phase-dependent
proteolytic degradation of TrfA by ClpCP. Additionally, a regulatory feedback loop was uncovered for a positive regulator of trfA,
whereby Spx represses one of its promoters, which in turns affects
trfA transcription. TrfA was also identified as the adaptor involved
in the ClpCP-mediated degradation of antitoxins, revealing a role
for the modulation of toxin activity in S. aureus (34). Together,
these results reveal how the adaptor TrfA temporally tunes the
ClpCP-mediated protein degradation of several classes of proteins
involved in S. aureus physiology.
MATERIALS AND METHODS
Bacterial strains and culture conditions. Table 1 contains a list of the
bacterial strains used in these studies. E. coli strains were routinely grown
in LB, and S. aureus strains were routinely grown in Trypticase soy broth
(TSB). Both strains were grown with shaking at 250 rpm at 37°C. Cell
density was measured by determination of the absorbance (optical density
[OD]) at 650 nm using an 18-mm borosilicate glass tube in a Spectronic
20D⫹ spectrophotometer. Ampicillin (Amp; 50 g/ml), chloramphenicol (Cm; 10 g/ml), or erythromycin (Erm; 2.5 g/ml) was added to the
appropriate medium when required by a particular strain. To disrupt
transcription or protein synthesis, rifampin (200 g/ml) or erythromycin
(50 g/ml) was added to the cultures, respectively. Promoter induction of
pEPSA5 was performed using 0.1 to 0.5% xylose, when necessary. Thiol
stress was induced by the addition of 5 mM diamide [1,1-azo-bis(N,Ndimethylformamide); Sigma-Aldrich].
DNA manipulations. E. coli plasmid purification was performed using Qiagen miniprep kits (Qiagen) per the manufacturer’s instructions,
while plasmid isolation from S. aureus was performed as described previously (35). Plasmid transformations in S. aureus were achieved via electroporation with a MicroPulser apparatus (Bio-Rad), using RN4220 as an
intermediate between E. coli and relevant S. aureus strains.
Codon optimization of venus. To create a construct that yields a rapidly maturing fluorescent protein, the Venus gene was codon optimized
for S. aureus using the codon frequencies calculated from the S. aureus
COL genome, while avoiding the generation of additional restriction enzyme sites. Subsequently, 42-bp primers staggered to each neighboring
sequence by 21 bp were combined in assembly reactions using HiFi PCR
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Supermix (Invitrogen) to create ⬃300-bp fragments of venus, followed by
the addition of flanking primers at the 5= and 3= ends of each 300-bp
fragment using a new PCR. Following gel purification, equimolar
amounts of each fragment were combined for a second assembly reaction
with primers at the 5= and 3= ends of venus, and the PCR product was
purified and sequenced. Both the primers and S. aureus codon-optimized
venus sequences are available upon request.
Plasmid construction. To ensure the robust expression of our codonoptimized venus gene, we first cloned a strong phage repressor promoter
of saOUHSC_02234 from a lysogenized phage (36) into the EcoRI-XbaI
restriction sites of shuttle plasmid pSK236. To place venus under the control of the phage repressor promoter, we cloned venus together with an
upstream sarA ribosomal binding site into the SalI-PstI sites of pSK236.
To add the S. aureus SsrA tag GKSNNNFAVAA (25) to the C terminus of
Venus (in which the construct was designated venus-SsrA), the following
primers were used: 5=-AACTGCAGTTATGCTGCAACCTTGTAAAGTT
CATCCATTCC-3= and 5=-AACTGCAGTTAGGCAGCTACTGCGAAAT
TATTGTTTGATTTGCCAGTCTTGTAAAGTTCATCCATTCCT-3=. This
sequence diverges from that of Flynn et al. (25) by its lack of an alanine at its N
terminus, as this residue was not found in genomic sequences of clinical and
laboratory isolates (data not shown). To add the VAA tag to the C terminus of
Venus (in which the construct was designated venus-VAA), the following
primer was used in place of the second primer listed above: 5=-ACGCGTCG
ACGGAGGTTTTAAACATGGTTTCTAAAGGTGAA-3=. To construct a
separate recombinant plasmid for the induction of Venus expression, we
cloned venus and the venus-VAA variant into the EcoRI and BamHI sites of
pEPSA5 containing a xylose-inducible promoter (37).
For plasmid constructs capable of expressing trfA or spx under induction, we used a cloning strategy in pEPSA5 similar to the one used for
venus. Briefly, trfA or spx was amplified by PCR with a 5= codon-optimized
myc tag, and the amplified product was cloned into the EcoRI and BamHI
sites of pEPSA5. In addition, S. aureus SH1000 strains capable of overexpressing myc-tagged antitoxin genes from S. aureus under the control of
the xylose promoter of pEPSA5 were constructed as previously described
(22).
To generate an spx promoter reporter construct, we cloned the distal
P1 promoter or proximal P2 promoter region of spx (starting 245 bp or
102 bp before the spx start codon, respectively; amplification primers are
available on request) into the EcoRI and XbaI sites of pALC1484, a shuttle
plasmid containing a green fluorescent protein (GFP) reporter gene. Following sequencing verification, the plasmids were used to transform
RN4220 and subsequent strains.
Construction of deletion strains. All sequenced S. aureus genomes
contain the following three adaptor genes: mcsB (sa0482), trfA (sa0857),
and yjbH (sa0860). As our relevant clp deletion strains are constructed in
the S. aureus SH1000 background, we proceeded to construct deletion
mutants of these adaptor genes in strain SH1000. Deletion mutants were
constructed using the temperature-sensitive allelic replacement plasmid
pMAD (38). In brief, chromosomal regions 1,000 bp up- and downstream
of the gene of interest were amplified by PCR with primers proximal to the
deletion site, joined by gene sewing, ligated into pMAD, and transformed into RN4220 and then into SH1000. The mutant was then
generated by a temperature shift strategy to yield the mutant, as described previously (38). To generate a pMAD construct to complement a trfA deletion mutant, we inserted a DNA fragment with the
intact gene flanked by 1,000 bp on each side into pMAD, followed by
allelic replacement in the mutant. All constructs were verified by colony PCR and chromosomal sequencing.
Isolation of RNA and Northern blot hybridization. Overnight cultures of S. aureus were each diluted 1:1,000 and grown at 37°C with shaking at 250 rpm in 100 ml of TSB inside 500-ml sidearm flasks (flask/
medium ratio, 5:1). Cell density was monitored by determination of the
absorbance at 650 nm, and at the appropriate OD, aliquots of cells were
pelleted and flash frozen at ⫺80°C. RNA extraction was accomplished by
lysing the cells with 1 ml of cold TRIzol reagent (Invitrogen) and 0.25 ml
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TABLE 1 Strains and plasmids used in this study
Strain or plasmid

Genotype or characteristics

Source or reference

Strains
S. aureus
RN4220
SH1000
JM27
NCTC 8325-4 ⌬spx
NCTC 8325-4 spx complement
ALC4976
ALC4977
ALC4978
ALC4979
ALC4980
ALC4981
ALC5105
ALC6490
ALC6491
ALC7010
ALC7011
ALC7137
ALC7272
E. coli XL1-Blue

Heavily mutagenized derivative of NCTC 8325-4
NCTC 8325-4 with repaired rsbU gene
SH1000 ftsH::tetL
NCTC 8325-4 ⌬spx
NCTC 8325-4 spx mutant complemented with spx
SH1000 ⌬clpB
SH1000 ⌬clpC
SH1000 ⌬clpL
SH1000 ⌬clpQ
SH1000 ⌬clpX
SH1000 ⌬clpY
SH1000 ⌬clpP
SH1000 clpC mutant complemented with clpC
SH1000 clpP mutant complemented with clpP
SH1000 ⌬mcsB
SH1000 ⌬trfA
SH1000 ⌬yjbH
SH1000 trfA mutant complemented with trfA
General cloning strain

63
64
17
60
60
22
22
22
22
22
22
22
22
22
This work
This work
This work
This work
Agilent

Plasmids
pMAD
pEPSA5
pSK236
pALC1484
pALC6188
pALC6486
pALC6489
pALC6954
pALC6955
pALC7016
pALC7113
pALC7151
pALC7257
pALC7422
pALC7867
pALC7868
pALC7869
pALC7803
pALC7804
pALC7901

E. coli/S. aureus shuttle plasmid with the ori pE194ts; bgaB Ampr Ermr
Xylose-inducible shuttle vector; Ampr Cmr
S. aureus/E. coli shuttle vector with pUC19 cloned into the HindIII site of pC194
pSK236 with promoterless gfp-uvr, a cycle 3 gfp allele
pEPSA5 with mazE with a 3= myc tag and sarA ribosome binding site
pEPSA5 with axe1 with a 5= myc tag and sarA ribosome binding site
pEPSA5 with axe2 with a 5= myc tag and sarA ribosome binding site
pSK236 with a phage repressor promoter and codon-optimized venus
pSK236 with a phage repressor promoter and codon-optimized venus-VAA
pEPSA5 with codon-optimized venus-VAA and sarA ribosome binding site
pEPSA5 with spx with a 5= myc tag and sarA ribosome binding site
pEPSA5 with trfA with a 5= myc tag and sarA ribosome binding site
pMAD::trfA (sa0857) complement
pSK236 with a phage repressor promoter and trfA with a 5= myc tag
pMAD::⌬trfA (sa0857)
pMAD::⌬mcsB (sa0482)
pMAD::⌬yjbH (sa0860)
pALC1484 with the spx P1 promoter in EcoRI and XbaI sites
pALC1484 with the spx P2 promoter in EcoRI and XbaI sites
pSK236 with a phage repressor promoter and codon-optimized venus-SsrA

38
37
65
66
22
22
22
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work

of 0.1-mm-diameter silica/glass beads in a Mini-BeadBeater 8 apparatus
(Biospec Products) at its maximum setting for two 1-min pulses. RNA
purification and subsequent Northern analysis were performed as described previously (39).
Cell lysate preparation and Western blot analyses. Protein lysates
were prepared as described before (22) from cells grown in a fashion
similar to that for RNA extraction described above. At an OD of 650 nm
(OD650) of 1.1, growth was stalled with antibiotics (either 200 g/ml
rifampin or 50 g/ml erythromycin, depending on the experiment), and a
series of cells (10 ml each at a 15- or 30-min interval) were pelleted at 1°C,
flash frozen in liquid nitrogen, and stored at ⫺80°C. For lysis, the pellets
were thawed on wet ice, washed twice with ice-cold sample buffer (50 mM
Tris-HCl, pH 7.6, 5 mM EDTA), and resuspended in 200 l of sample
buffer to which 100 l of 0.1-mm-diameter silica/glass beads was added.
The cells were then disrupted in a Mini-BeadBeater 8 apparatus at its
maximum setting for two 1-min pulses with a 1-min rest, followed by
centrifugation at 20,000 ⫻ g for 15 min at 1°C. Halt protease inhibitors
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(1⫻; Thermo Fisher) were then added to the lysates, and their protein
concentrations were determined by Bradford assay using an FL600 microplate reader (BioTek Instruments).
For Western blot assays, SDS-PAGE was first performed with 30 g
of lysate proteins, and then the proteins were transferred to polyvinylidene difluoride (PVDF) membranes using an iBlot Western blot
transfer system (Invitrogen). Following blocking in 5% milk in Trisbuffered saline with Tween (TBS-T; 150 mM NaCl and 10 mM Tris, pH
8.0, with 0.1% [vol/vol] Tween 20) for at least 30 min, the membranes
were then incubated with either mouse anti-GFP (Abcam) or mouse antiMyc (Cell Signaling) antibodies in TBS-T for 2 h. The membranes were
then washed in TBS-T and incubated with horseradish peroxidase-conjugated goat anti-mouse secondary antibody (Jackson ImmunoResearch).
After additional washing, enhanced chemiluminescence (ECL) reagent (GE Healthcare) was added and the membrane was exposed to
film. Scanned images from nonsaturated exposed film were then analyzed densitometrically using ImageJ software, and the half-lives of the
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FIG 1 Venus and Venus-VAA protein levels in S. aureus SH1000 wild-type cells following rifampin treatment. (A) Western blot analysis of lysates of wild-type
SH1000 with either pALC6954 (producing Venus), pALC6955 (producing Venus-VAA), or pALC7901 (producing Venus-SsrA) grown to an OD650 of 1.1 after
rifampin treatment (200 g/ml). The blot was probed with an anti-GFP primary antibody and then a secondary horseradish peroxidase-conjugated goat
anti-mouse antibody. The experiments were repeated three times, and a representative blot of each set of lysates is displayed. (B) Venus fluorescence emitted from
strains ALC6954 (producing Venus; circles) and ALC6955 (producing Venus-VAA; squares) either stalled by 50 g/ml erythromycin after reaching an OD650 of
1.1 (open symbols) or not treated with drug (closed symbols). The fluorescence at 540 nm was observed following excitation at 515 nm and normalized to the cell
density at the OD650. Values were then compared to the fluorescence at time zero. The result for each time point is the mean and standard deviation of three
biological replicates. (C) Degradative laddering of Venus-VAA. The lysate from wild-type SH1000 expressing Venus-VAA from pALC6955 was resolved and
immunoblotted with an anti-GFP primary antibody and a secondary horseradish peroxidase-conjugated goat anti-mouse antibody. Exposure to film was
extended to reveal lower-molecular-mass bands. Numbers on the left are molecular masses (in kilodaltons).

proteins of interest were calculated using Prism (version 5) software
(GraphPad).
Fluorescence analysis. To analyze the fluorescence of S. aureus cells
expressing Venus or its variants, cells were monitored using one of two
machines. For single time points, results for 200 l of cells at various time
points were read in a 96-well plate (Costar plate 3632) in an FL600 plate
reader (BioTek) with 515-nm excitation and 540-nm emission filters
(Omega Optical). In experiments with multiple time points, 150 l of cells
was shaken in a 96-well plate (Costar plate 3632) with a heated top plate to
prevent condensation at 250 rpm and 37°C in a Tecan Infinite M1000 Pro
apparatus (Tecan). Fluorescence was recorded using 515-nm excitation
and 528-nm emission filters and 650-nm absorbance filters. In both cases,
data are reported as the level of fluorescence per absorbance unit to normalize the cell density.

RESULTS

Establishing an in vivo assay for SsrA-tagged proteins in S. aureus using Venus fluorescence. During translation, ribosomes
may stall for a variety of reasons, including stress, starvation, or
premature degradation of the template mRNA. To reset the translational machinery, a hybrid RNA called transfer-messenger RNA
(tmRNA) enters the open A site of the ribosome, shifting translation from the degraded or truncated mRNA to a small open reading frame with a stop codon within the tmRNA (40). The resulting
11-amino-acid tag, called the SsrA tag, is appended to the C terminus of the nascent but truncated protein and is then recognized
as a signal for rapid degradation by ClpAP and ClpXP in E. coli
(32) or ClpXP in B. subtilis (33). As the half-lives of SsrA-tagged
proteins are short, reportedly ⬍10 min (41), the tracking of such
proteins is difficult in vivo. To investigate this system in S. aureus
and to obtain an improved sensitivity compared to that obtained
with the slowly folding non-codon-optimized cycle 3 gfp (42), we
utilized a fast-folding yellow fluorescent protein (YFP)-tagged Venus variant (SEYFP-F46L) (43) which exhibits an accelerated ox-
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idation step as a result of the F46L mutation, leading to rapid and
enhanced fluorescence (43). In S. aureus, the SsrA tag has been
predicted to be AGKSNNNFAVAA (25), but it has never been
tested. Given that the N-terminal alanine of the predicted S. aureus sequence is not conserved in sequenced genomes (data not
shown), we chose instead to append the sequence GKSNNNF
AVAA to the C terminus of Venus. Furthermore, identifying the
minimal unit of SsrA necessary for degradation was also of interest. Based on prior work in other organisms (44) suggesting that
the final 3 amino acids are sufficient as a degradation signal, we
created an additional construct appending the amino acids VAA
to the C terminus of Venus.
Following introduction of the recombinant plasmids into S.
aureus strain SH1000, initial work revealed significant fluorescence, while the cells exhibited no retardation of growth in the
presence of any of these plasmids (data not shown). To verify that
the SsrA tag and the abbreviated VAA tag on Venus were produced
and functional, cells with the venus construct (pALC6954), the
venus-VAA construct (pALC6955), or the venus-SsrA construct
(pALC7901) were grown in TSB as described in Materials and
Methods until the OD650 reached 1.1, whereupon 200 g/ml of
rifampin was added to the culture and samples were withdrawn at
predetermined time points for 2 h. Western blot analysis of wholecell lysates probed with a mouse anti-GFP antibody capable of
detecting Venus showed that the Venus protein levels rapidly decreased in both the strain containing Venus-VAA (pALC6955)
and the strain containing Venus-SsrA (pALC7901), but no equivalent decrease was observed in cells producing untagged Venus
(pALC6954) (Fig. 1A). This finding implied that Venus is stable in
S. aureus and that addition of SsrA, notably, just the last 3 amino
acids of such a tag (VAA), was sufficient to destabilize it. Densitometric analysis indicated that the expressed Venus-VAA construct
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FIG 2 Venus levels in clp and adaptor mutant strains of SH1000. (A) Venus fluorescence analysis of overnight cultures of S. aureus strains containing pALC6955
(producing Venus-VAA). Venus fluorescence values (excitation and emission, 515 nm and 540 nm, respectively) were normalized to the OD650 values and then
reported as a percentage of the wild-type levels. Each value is the mean and standard deviation of three biological replicates. *, statistically significant differences
(P ⬍ 0.005) compared to the wild type measured by Student’s unpaired t test. (B) Western blot of Venus-VAA protein levels in S. aureus SH1000 wild-type and
⌬clp cells containing pALC7016 with a xylose-inducible promoter (producing Venus-VAA) after transcriptional arrest by rifampin (200 g/ml). Strains were
grown to an OD650 of 1.1 and then treated with rifampin (200 g/ml), and samples were taken every 30 min. Whole-cell lysates of these samples were then
separated by SDS-PAGE on a 20% gel and transferred to PVDF for immunoblotting with an anti-GFP primary antibody and subsequently with a horseradish
peroxidase-conjugated goat anti-mouse antibody. The experiments were repeated three times, and representative blots are displayed. (C) Western blot of
Venus-VAA protein levels in S. aureus SH1000 wild-type and adaptor mutant strains containing pALC7016 (producing Venus-VAA). Whole-cell lysates of 0.5%
xylose-induced samples obtained at different time points after rifampin treatment were resolved, blotted, and probed as described above for panel B. The
experiments were repeated three times, and representative blots are displayed.

had a half-life of 47 min, while the Venus-SsrA construct had a
half-life of 27 min, suggesting that while VAA is sufficient for
degradation, other residues of the SsrA tag may play a role in
proteolytic degradation.
To pursue our observation that the VAA residues of SsrA were
sufficient for proteolytic degradation, we examined whether there
was a functional correlation of protein degradation to fluorescence loss. To accomplish this, we used erythromycin (50 g/ml)
at an OD650 of 1.1 to stop protein synthesis (rifampin interferes
with the fluorescence spectrum), followed by monitoring of cell
density and fluorescence over 6 h. As seen in Fig. 1B, Venus and
Venus-VAA levels remained largely unchanged over time in the
absence of erythromycin. However, when erythromycin was
added, the fluorescence levels of Venus-VAA (ALC6955) began to
decrease with a half-life of 75 min, whereas the levels in ALC6954
(Venus) remained unchanged. This result suggested that the fluorescence associated with the degradation of Venus with the SsrA
tag was reduced in the cell, albeit more slowly than the reduction
of the protein (half-life, 47 min), as determined by Western blotting (Fig. 1A). The reason for this discrepancy is unknown but
may be due to either Venus-VAA molecules retaining the capacity
for emitting fluorescence even when partially degraded or the formation of in vivo foci that affect overall fluorescence (45). In support of the former possibility, we observed a laddering of lowermolecular-weight bands in Western blots of the Venus-VAA lanes
following addition of rifampin (Fig. 1C), suggesting that proteolysis occurred in a stepwise fashion.
clpCP instead of clpXP is involved in SsrA degradation in S.
aureus. With the availability of a reporter construct capable of
displaying the relative amount of an SsrA- or VAA-tagged protein
in a cell, we examined the role of ATP-dependent proteases and
their cognate chaperones in the breakdown of SsrA-tagged protein
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in various clp mutants in our collection using the Venus-VAA
construct. As shown in Fig. 2A, Venus-VAA levels were higher in
overnight cultures of ⌬clpC and ⌬clpP strains than in those of
wild-type and other protease and chaperone mutant strains. Similar results were also observed in clpC and clpP mutants when
grown for 6 h (data not shown). Interestingly, the amount of Venus-VAA that accumulated in the ⌬clpP mutant was not as high as
that which accumulated in the ⌬clpC mutant. Given that ⌬clpP
strains exhibit lower growth rates, smaller colony sizes, and altered
metabolic intracellular environments compared to those of the
wild type (16), it is conceivable that these altered phenotypes may
have accounted for the lower fluorescence in the clpP mutant than
the clpC mutant. We next examined whether this difference in
fluorescence between the ⌬clpC and ⌬clpP mutants was actually
reflected in degradation of the Venus-VAA protein. Accordingly,
we cloned the venus-VAA gene into pEPSA5, which allows VenusVAA expression upon xylose induction, and then introduced this
plasmid, pALC7016, into SH1000, ⌬clpC, and ⌬clpP strains.
Western blots of cell lysates taken from these xylose-induced cells
following rifampin treatment were probed with anti-GFP antibody, revealing increased half-lives of Venus-VAA in the clpC and
clpP mutants during 2 h of transcriptional stalling, while degradation was restored in the complemented clpC and clpP mutants
(Fig. 2B). In contrast, a similar effect was not seen in the clpX
mutant. Taken together, these data indicate that ClpC is the chaperone involved in SsrA-mediated degradation in S. aureus, contrary to the finding in E. coli (32) and B. subtilis, where ClpX is the
primary chaperone that facilitates SsrA-mediation degradation
(33).
TrfA is necessary to break down SsrA in S. aureus. To determine if other additional components were involved in degrading
SsrA-tagged proteins in S. aureus, we examined the role(s) played
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FIG 3 Venus-VAA levels in the wild type and the ⌬trfA mutant over 20 h of growth. The raw Venus fluorescence of the S. aureus SH1000 wild-type, ⌬trfA, and

trfA-complemented (trfA⫹) strains containing pALC6955 (producing Venus-VAA) over 20 h is shown. Cell densities at an OD650 were measured, while Venus
fluorescence was detected at 540 nm (black lines), with each value representing the mean of three biological replicates.

by various adaptor proteins. The S. aureus genome contains genes
for three known adaptors: mcsB (sa0482), trfA (sa0857), and yjbH
(sa0860). We first transformed the pEPSA5-Venus-VAA construct pALC7016 into mcsB, trfA, and yjbH mutants. Western blot
analysis of Venus-VAA breakdown in these adaptor mutants with
pALC7016, grown to an OD650 of 1.1, after which rifampin was
added, showed that only trfA was involved in degrading VenusVAA (Fig. 2C). These data indicate that TrfA, together with
ClpCP, controls SsrA-mediated degradation in S. aureus through
the 3 terminal amino acids of the SsrA tag.
To examine how deletion of trfA impacted SsrA degradation at
various phases of growth, we sampled fluorescence levels during
20 h of growth in TSB medium for wild-type, ⌬trfA, and trfAcomplemented strains expressing Venus-VAA (Fig. 3). Starting
from overnight cultures, strains were back-diluted 1/100 and
grown to an OD650 of 0.6, whereupon they were normalized to an
OD650 of 0.1, and 150 l of this culture was aliquoted into a well of
a 96-well plate. Cell growth was comparable among the three
strains when incubated at 37°C with shaking for 20 h (data not
shown). Analysis of the strains at these time points revealed that
the ⌬trfA strain (Fig. 3, squares) produced much higher levels of
both raw and normalized fluorescence at all time points than the
wild-type (Fig. 3, diamonds) and trfA-complemented (Fig. 3, circles) strains. This suggests that Venus-VAA levels are generally
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elevated in a ⌬trfA strain relative to those in the wild-type and
complemented strains.
The fluorescence intensity of Venus-VAA and its 47-min halflife make it is possible to uncover conditional changes of fluorescence between strains. Specifically, the raw fluorescence in all
strains (Fig. 3) increased at various rates in early logarithmic phase
up through 3.5 h, but at late logarithmic phase (3.5 to 5.5 h),
Venus-VAA levels began to decrease in the wild-type and trfAcomplemented strains but not a ⌬trfA strain (Fig. 3). This decrease
or flattening of both the raw and normalized fluorescence of
strains containing trfA was maintained well into stationary phase,
while the fluorescence of Venus-VAA continued to climb in the
⌬trfA strain. This suggests that trfA has a lesser role in SsrA regulation in early and mid-logarithmic phase (when there was no
decrease in fluorescence in the wild type) but gains in importance
as cells begin to exit logarithmic phase and enter stationary phase.
Transcriptional regulation of trfA. trfA is transcribed from
three promoters, generating transcripts of closely related sizes of
751, 818, and 898 bases, which can be seen as a single transcript in
a 0.7% agarose gel (28). The changes to trfA transcription during
various growth phases remain unclear, however. To investigate
trfA transcript levels over time, we conducted Northern blot analyses using RNA taken from SH1000 cells grown to various time
points. Our data demonstrate (Fig. 4A, unstimulated time points)
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FIG 4 Transcriptional and posttranslational regulation of trfA. (A) Northern blot of trfA during growth and thiol stress. S. aureus SH1000 was grown to various
ODs under conditions with and without 5 mM diamide for thiol stress. The RNAs obtained from these cells (20 g each) were resolved on a denaturing agarose
gel, blotted to a Hybond XL membrane, and hybridized with a 300-bp 32P-radiolabeled trfA DNA fragment. The 16S rRNA of the ethidium bromide-stained gel
was used as the loading control for the blot. The percentages of the trfA transcript at a given time point relative to the amount of trfA transcript at an OD650 of
0.7 (set equal to 100%, as indicated in brackets), determined by densitometric analysis, are reported at the top of the image. (B) Western blots of whole-cell lysates
of various SH1000 strains transformed with pALC7151 (producing TrfA with an N-terminal myc tag). Cells were induced with 0.1% xylose at an OD650 of 1.1 and
then treated with rifampin (200 g/ml). Samples taken every 30 min were immunoblotted with a mouse anti-Myc primary antibody, followed by a horseradish
peroxidase-conjugated goat anti-mouse antibody. The experiments were repeated three times, and representative blots are displayed. (C) Western blot analyses
of TrfA in wild-type strain SH1000 at various time points following rifampin treatment. Wild-type strain SH1000 containing pEPSA5 expressing N-terminally
Myc-tagged TrfA was induced with 0.1% xylose at early logarithmic phase (OD650 ⫽ 0.7), late logarithmic phase (OD650 ⫽ 1.1), or stationary phase (OD650 ⫽
1.7) and then treated with rifampin (200 g/ml). Samples were then immunoblotted with an anti-Myc primary antibody, followed by a horseradish peroxidaseconjugated goat anti-mouse antibody. The experiments were repeated three times, and representative blots are displayed.

that the trfA transcripts in SH1000 increased from early log phase
and peaked at late log phase (OD650, 1.1), followed by a significant
decrease in stationary phase to a point where transcription was all
but halted during deep-stationary-phase culture (at 24 h).
trfA has also been shown to be responsive to certain stresses
(28). Reverse transcription-PCR (RT-PCR) analysis showed that
one or more of the trfA transcripts were elevated following antibiotic or thiol stress. To evaluate the resiliency and duration of this
trfA induction, we examined trfA levels following the addition of 5
mM diamide. S. aureus cells were grown to an OD650 of 0.7 and
then split for continued growth or challenge with 5 mM diamide.
Samples were withdrawn 30 and 60 min later (corresponding to
OD650s of 1.1 and 1.4, respectively). As seen in Fig. 4A, comparing
the results at time points with and without diamide, the level of
transcription of trfA more than doubled at 30 min after diamide
addition relative to that of untreated cells at an analogous OD.
Remarkably, this induction of trfA transcripts nearly vanished at
60 min after diamide induction (i.e., at an OD650 of 1.4), presumably due in part to the rapid inactivation of diamide within 20 to
30 min after addition (Ana Posada, personal communication).
TrfA is degraded by ClpCP. The adaptor MecA of B. subtilis
shares 36% amino acid sequence identity to TrfA, primarily in the
first 80 amino acids. MecA controls competence by targeting the
transcriptional regulator ComK for degradation through ClpCP
(46), and MecA is itself proteolytically regulated by this system
(46). Although S. aureus does not contain the competence machinery of B. subtilis, it is of interest to ascertain if S. aureus utilizes
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a similar method of posttranslational regulation. Accordingly, we
induced the expression of TrfA with a codon-optimized N-terminal Myc tag using the xylose-inducible plasmid pEPSA5. The Myc
tag was chosen because it has been demonstrated not to alter the
pattern of proteolysis in other proteins (22). At an OD650 of 0.6, S.
aureus cells were induced with 0.2% xylose and grown to an OD650
of 1.1. At this point, rifampin was added to stall transcription and
samples were withdrawn at predetermined time points for 2 h.
Whole-cell lysates of these aliquots were then examined by Western blotting with anti-Myc antibodies. As observed in Fig. 4B,
TrfA levels decreased rapidly in the wild-type strain SH1000 with
an ⬃22-min half-life, as determined by densitometric analysis.
Similar rates were seen for the clpB, clpQ, and clpX deletion mutants. However, TrfA levels remained relatively steady in the ⌬clpC
and ⌬clpP strains, indicating that the ClpCP protease system controls the degradation of TrfA, as it does in B. subtilis. These data,
combined with the transcriptional transiency of trfA induction
after thiol stress, suggest that TrfA levels can be rapidly induced
under specific conditions and just as rapidly recede to preinduced
levels following the cessation of a specific stress.
The combination of TrfA’s proteolytic degradation and its
transcriptional peak during late logarithmic phase gives a sense of
how TrfA operates in the cell. However, to fully understand how
TrfA changes during growth in medium, we were interested to
determine whether the TrfA degradation rate was maintained at
other growth phases. Similar to our previous time point experiments, we grew wild-type SH1000 expressing N-terminally Myc-
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FIG 5 spx regulation of trfA and spx transcription. (A) GFP fluorescence driven by the spx P1 promoter on a shuttle plasmid containing a GFP reporter
(pALC7803) in the ⌬spx and spx-complemented strains at the 4- and 8-h time points (late log and early stationary phases, respectively). To minimize variations
in fluorescence attributable to cell density, the data are presented as the average number of fluorescence units for triplicate samples per unit of absorbance at 650
nm. *, a statistically significant difference (P ⬍0.05) compared to the results for spx-complemented strain, as measured by Student’s unpaired t test. (B) Northern
blot of spx transcription from S. aureus SH1000 at various growth phases with and without 5 mM diamide. RNA (20 g each) was resolved on a denaturing
agarose gel, blotted as described above, and probed with a 300-bp 32P-radiolabeled spx DNA probe. As a loading control, ethidium bromide-stained 16S rRNA
was included, and the results are shown at the bottom. Arrowheads, sizes of the transcripts generated from the P1 and P2 spx promoters. (C) Northern blots of
RNA extracted from the S. aureus SH1000 and ⌬trfA strains at the late exponential phase of growth (OD650 ⫽ 1.1) and probed with a 300-bp 32P-radiolabeled spx
probe. Faint bands are identified by arrowheads to the side of each lane. The numbers to the left indicate kilobases.

tagged TrfA from pEPSA5 to various ODs under conditions of
xylose induction and, following the addition of rifampin, took
samples at various time points over 2 h. Western blots of lysates of
these cells were probed with anti-Myc antibody and revealed that
while cells in early logarithmic phase degraded TrfA similarly to
those in late logarithmic phase (half-life, ⬃22 min), cells in stationary phase took longer to degrade TrfA (half-life, ⬃37 min)
(Fig. 4C). This suggests that even with the decreased transcription
of trfA in stationary phase (Fig. 4A), TrfA may still be present in
stationary-phase cells.
spx activates trfA but represses its own promoter. Previous
studies of spx transcription by RT-PCR have shown that the gene
product of spx likely activates one or more of these transcripts of
trfA (28). Spx is a thiol-sensitive transcriptional regulator that is
itself proteolytically regulated and is responsible for controlling
the adaptation and survival of S. aureus in environments with
oxidative stress.
To examine whether the transcriptional regulation of trfA by
spx was subject to any autoregulation, we constructed transcriptional fusions of the spx P1 (distal) and P2 (proximal) promoters
linked to GFP, as described in Materials and Methods, to yield
pALC7803 and pALC7804, respectively. These plasmid constructs
were used to transform the ⌬spx mutant and its complemented
strain of S. aureus. The results revealed that for the P2 promoter
construct pALC7804, GFP levels were equivalent between the
⌬spx and complemented strains (data not shown). However, GFP
fluorescence levels were consistently higher in the ⌬spx strain with
the P1 promoter (Fig. 5A) at multiple time points than in its complemented strain. These data indicate that spx represses its own
distal (P1) promoter but does not regulate its proximal (P2) promoter.
To better assess the growth conditions under which Spx represses its own promoter, we examined spx transcription at the
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same times of growth used for measuring trfA transcription (Fig.
4A). Surprisingly, spx transcription was relatively constant
through log and early stationary phases under unstimulated conditions (Fig. 5B). However, following the addition of 5 mM diamide, spx transcription was greatly reduced after 30 min
(OD650 ⫽ 1.1 with diamide) and recovered after 60 min as the
diamide effect tapered (OD650 ⫽ 1.4 with diamide). Interestingly,
protein levels of Spx actually increase following diamide treatment in both B. subtilis and S. aureus (31, 47). This increase in Spx
levels alongside a corresponding decrease in spx transcript levels
following diamide treatment (Fig. 5B), as well as the increase in
spx promoter fusion activity in a ⌬spx strain in general (Fig. 5A),
supports our notion that the Spx protein represses its own transcription in S. aureus.
We also examined the amount of transcriptional read-through
that occurs from the spx locus into the adjacent gene, trfA (Fig.
5C). A rho-independent terminator was predicted between spx
and the adjacent trfA gene (⫺⌬G ⫽ 14.5 kcal/mol) (48), so to
examine its effect on trfA transcription during cultured growth,
we isolated RNA from wild-type strains grown to mid-log phase
(OD650 ⫽ 1.1). In addition to the two previously noted spx transcripts (28), several putative read-through bands at ⬃1.4 kb were
also observed with extended exposure (Fig. 5C, arrowheads on the
left). Relative to the smaller spx transcripts, these were estimated
by densitometric analysis to be 3 to 4% of total spx transcripts.
Importantly, these larger bands decreased in size in the ⌬trfA
strain, corresponding to the reduction of trfA (720 bp) in the
mutant. Therefore, the terminator between spx and trfA is strong
and able to terminate transcription in ⬃95% of cases.
TrfA does not regulate Spx protein levels in S. aureus. Spx has
been shown to be proteolytically regulated by YjbH in S. aureus
(31) and B. subtilis (49). However, YpbH, a MecA paralog with
which TrfA shares 26% identity, also recognizes and degrades Spx
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FIG 6 Role of S. aureus adaptors in Spx degradation. Western blots of whole-

cell lysates of the SH1000 wild-type, ⌬trfA, ⌬yjbH, ⌬clpC, ⌬clpX, and ⌬clpP
strains with pALC7113 (producing Spx with an N-terminal myc tag). Cells
were grown to an OD650 of 1.1 with 0.1% xylose and then treated with rifampin
(200 g/ml). Cell lysates taken every 30 min were immunoblotted with a
mouse anti-Myc primary antibody, followed by a horseradish peroxidase-conjugated goat anti-mouse antibody. The experiments were repeated three times,
and representative blots are displayed.

in B. subtilis (50). To determine whether YjbH and TrfA share Spx
as a substrate or whether another adaptor, such as McsB, was
involved, we exogenously expressed Spx with an N-terminal myc
tag from pALC7113 in various clp and adaptor deletion strains and
tracked the degradation rates in transcriptionally stalled cells. As
shown in Fig. 6, only in the yjbH mutant did the level of Spx persist
through 120 min after rifampin treatment, whereas Spx was barely
detectable at 30 min after rifampin treatment in the wild-type,
⌬mcsB, and ⌬trfA strains. Furthermore, Spx levels remained high
in the ⌬clpX and ⌬clpP strains but not the ⌬clpC strains. Together,
these data indicate that only yjbH acts as the facilitator of Spx
breakdown in S. aureus through the ClpXP system.
TrfA is the adaptor regulating S. aureus antitoxin degradation. Toxin-antitoxin systems are small genetic loci that serve a
variety of functions, from plasmid maintenance, chromosomal
stabilization, and persister formation to a bacterial form of programmed cell death (51). Several classes of toxin-antitoxin systems exist, based in part on whether the antitoxin is RNA (type I
and type III) or protein (type II). In all cases, the antitoxin is
short-lived due to its rapid degradation but is stabilized by its
binding to its cognate toxin. The antitoxin also inactivates the
toxin, protecting the bacteria until levels of antitoxin drop in response to a variety of environmental stresses (52). There are three
known type II toxin-antitoxin systems in S. aureus, Axe1/Txe1,
Axe2/Txe2 and MazEF, all of which are known to be proteolytically regulated by ClpCP (22). Given that TrfA works with ClpCP
to degrade SsrA-tagged proteins in S. aureus, we wanted to determine whether TrfA also contributed to antitoxin degradation. For
this purpose, the wild-type strain SH1000 and its isogenic trfA
mutant were individually transformed with recombinant pEPSA5
plasmids carrying the antitoxin gene mazE, axe1, or axe2. For detection, we attached either a 5= or 3= myc tag (depending on the
success of expression) to the antitoxin genes (Table 1) (22). At an
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FIG 7 Degradation of antitoxins in trfA mutants. The SH1000 wild-type and
⌬trfA strains with either pALC6188 (mazEsa), pALC6486 (axe1), or pALC6489
(axe2) were grown to an OD650 of 1.1 with 0.1% xylose and then treated with
rifampin (200 g/ml). Cell lysates taken every 30 min were immunoblotted
with an anti-GFP primary antibody, followed by a horseradish peroxidaseconjugated goat anti-mouse antibody. The experiments were repeated three
times, and representative blots are displayed.

OD650 of 0.6, cells were induced with 0.2% xylose and grown to an
OD650 of 1.1, at which point the cells were transcriptionally stalled
by addition of rifampin. Western blots of whole-cell lysates from
these time points were probed with an anti-Myc antibody, disclosing that the levels of S. aureus MazE (MazEsa), Axe1, and Axe2 all
remained constant in the ⌬trfA strain for 120 min after rifampin
treatment, while those of the parental strain decreased rapidly
after 30 to 60 min (Fig. 7). Degradation rates comparable to the
rate for the wild type were also observed in the mcsB and yjbH
mutants of S. aureus (data not shown). Together, these results
demonstrate that the adaptor TrfA facilitates antitoxin degradation via ClpCP in S. aureus (22), hence linking a new set of proteins to adaptor-mediated proteolysis in bacteria.
DISCUSSION

S. aureus cells adjust the levels of their intracellular proteins
through alterations in either transcriptional priorities or degradation rates. Chaperones and adaptors assist with the latter by tuning
the substrate specificity of various proteases, allowing proteins to
be selectively removed. One way that regulated proteolysis is utilized by many bacteria is to recover from errors in translation that
may result in stalled ribosomes. In this process, tmRNA, a tRNA/
mRNA hybrid that contains a small open reading frame for an
11-amino-acid tag called SsrA, enters the A site of the stalled ribosome, and as translation restarts, it is appended to the C terminus
of the nascent protein. When newly tagged protein is freed from
the ribosome, SsrA is then recognized as a signal for degradation.
This is performed by both ClpXP and ClpAP (32, 53) in E. coli,
while in B. subtilis only ClpXP is used (33).
Interestingly, we discovered that SsrA-mediated proteolysis in
S. aureus is performed not by ClpXP but by ClpCP (Fig. 2A and B).
Previous work has shown that ClpX is involved in regulating toxin
production and virulence in S. aureus (16, 54), while ClpC plays a
modulatory role in responding to stress, metabolic changes, and
starvation (23). Therefore, it is not surprising that the degradation
of SsrA-tagged proteins in S. aureus falls under the regulation of
ClpCP (Fig. 8). Furthermore, SsrA degradation by proteases other
than ClpXP and ClpAP is not without precedent, as Lon is used in
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FIG 8 Proposed model for TrfA regulation and activity in S. aureus. The adaptor TrfA associates with ClpCP to selectively degrade SsrA-tagged proteins and class
II antitoxins, such as MazEsa. TrfA is itself degraded by ClpCP, which gives TrfA temporal nuance. The transcription of trfA is initiated from three upstream
promoters, at least one of which is positively regulated by Spx. Spx activity is controlled by the degradation of the Spx protein via ClpXP and YjbH under normal
conditions and with decreased proteolysis during oxidative, thiol, or antibiotic stress. Spx represses its own distal P1 promoter, creating a negative-feedback loop
where less spx is transcribed during such stresses. X, ClpX; P, ClpP; C, ClpC.

such a capacity in the small genome of Mycoplasma (55), and Tsp
(56), Lon (57), and FtsH (58) are all used in E. coli degradation of
the SsrA tag, albeit at a lower frequency than ClpXP and ClpAP.
While the reason that S. aureus swapped ClpXP for ClpCP in such
a role is not known, ClpC in S. aureus shares some homology to
ClpA in E. coli (36% identity, 56% similarity). It is possible that S.
aureus (or a progenitor of it) utilized both ClpC/ClpA and ClpX
for SsrA-mediated breakdown in a manner similar to that in
which they are utilized in E. coli. However, as this bacterium
evolved and ClpC became dominant in controlling the stress response and ClpX became dominant in controlling virulence, the
ability of ClpX to degrade SsrA-tagged proteins may have become
less of a necessity and ultimately lost entirely.
In E. coli, adaptors have long been known to complement
chaperones in controlling SsrA-mediated degradation. For example, the adaptor SspB normally competes for the same SsrA motif
as ClpA, blocking its recognition of SsrA-tagged proteins (25).
SspB levels increase during heat shock (25), effectively redirecting
ClpAP to degrade other targets, including misfolded proteins. No
homologs of SspB or any other E. coli adaptors exist in S. aureus, so
the mechanism by which TrfA mediates SsrA-mediated degradation in S. aureus may be novel (Fig. 8). Although the 3 C-terminal
amino acids of the SsrA tag are sufficient for TrfA-mediated degradation of SsrA-tagged proteins in S. aureus, it is plausible that an
additional factor(s) may mediate recognition of the entire native
SsrA tag by ClpCP since Venus-SsrA appears to be degraded faster
than Venus-VAA (Fig. 1A). Furthermore, as TrfA seems to have
the greatest influence on SsrA degradation during late logarithmic
and early stationary phases, the yet unidentified adaptor(s) may
assist with degradation during other growth states.
The regulation of TrfA has also begun to be unraveled by our
studies. Similar to MecA in B. subtilis (46), TrfA is degraded by the
very protease that it assists in proteolysis. The 22-min half-life of
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TrfA likely ties its activity to its transcription rate, suggesting that
TrfA functions largely during logarithmic and early stationary
growth phases, as well as to the oxidative stress response. In the last
case, the transcription of trfA is upregulated in an Spx-dependent
manner (28, 59), but it is quickly restored to baseline levels following abatement of thiol-related stresses (Fig. 4A). Such a pulse
of transcription during these oxidative stresses could temporarily
redirect ClpCP to process more TrfA-specific targets.
The thiol stress-sensitive transcriptional regulator Spx is degraded by ClpXP under normal growth conditions (60), but it is
stabilized during oxidative stress in S. aureus (28, 31), allowing
levels to rise. YjbH has been shown to contribute to this regulation
in S. aureus (31), but YpbH, an adaptor in B. subtilis that has 26%
identity to TrfA, has been shown to also control Spx degradation
(50). We clarified this uncertainty in S. aureus by determining that
only YjbH regulates Spx degradation (Fig. 6 and 8).
In B. subtilis, one of the three promoters of spx is upregulated
following thiol stress (61), which further contributes to an increase in Spx levels. On the basis of our data, an alternative system
appears to exist in S. aureus, where Spx (directly or indirectly)
represses its own promoter. Accordingly, following the increase in
Spx levels after exposure to 5 mM diamide, the transcription of spx
is repressed. Considering the spx-dependent activation of trfA,
this suggests that Spx can act as both an activator and a repressor
in S. aureus. This brings the Spx function in line with that in B.
subtilis, wherein it functions both to enhance RNA polymerase
activity (47) and to act as an anti-alpha factor repressing transcription (62).
Besides SsrA-tagged proteins, our studies here also expand the
set of proteins regulated by TrfA to include the labile antitoxins of
the type II toxin-antitoxin systems (Fig. 7 and 8). This finding is of
interest to us because we have shown previously that ClpCP is the
major proteolytic system for the degradation of class II antitoxins
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in S. aureus (22). While these protein-based antitoxins have been
known to be degraded by a variety of ATP-dependent proteases
and chaperones (52), to our knowledge, this is the first time that
an adaptor has been linked to antitoxin degradation. As toxinantitoxin systems are intimately linked to environmental and antibiotic-induced stresses, our results indicate that an adaptor such
as TrfA may also participate in this stress response by modulating
the degradation of antitoxins in S. aureus.
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